Original Article
Hydrocortisone for the treatment of refractory hypotension: a randomised controlled trial
Hidrocortisona para el tratamiento de hipotensión refractaria: ensayo clínico controlado y aleatorizado
G. Salasa, M. Travagliantib, A. Leoneb, C. Couceiroa, S. Rodríguezc, D. Fariñaa,
Corresponding author
a Área de Terapia Intensiva Neonatal, Hospital de Pediatría Prof. Dr. Juan P. Garrahan, Ciudad Autónoma de Buenos Aires, Argentina
b Área de Farmacia, Hospital de Pediatría Prof. Dr. Juan P. Garrahan, Ciudad Autónoma de Buenos Aires, Argentina
c Docencia e Investigación, Hospital de Pediatría Prof. Dr. Juan P. Garrahan, Ciudad Autónoma de Buenos Aires, Argentina
Read
9532
Timeswas read the article
3177
Total PDF
6355
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 73 | 31 | 104 |
| 2025 5 | 137 | 33 | 170 |
| 2025 4 | 158 | 31 | 189 |
| 2025 3 | 127 | 38 | 165 |
| 2025 2 | 109 | 39 | 148 |
| 2025 1 | 97 | 28 | 125 |
| 2024 12 | 75 | 39 | 114 |
| 2024 11 | 108 | 71 | 179 |
| 2024 10 | 87 | 67 | 154 |
| 2024 9 | 89 | 60 | 149 |
| 2024 8 | 104 | 71 | 175 |
| 2024 7 | 103 | 48 | 151 |
| 2024 6 | 89 | 45 | 134 |
| 2024 5 | 70 | 51 | 121 |
| 2024 4 | 69 | 31 | 100 |
| 2024 3 | 74 | 39 | 113 |
| 2024 2 | 109 | 32 | 141 |
| 2024 1 | 90 | 30 | 120 |
| 2023 12 | 79 | 38 | 117 |
| 2023 11 | 80 | 34 | 114 |
| 2023 10 | 101 | 27 | 128 |
| 2023 9 | 78 | 35 | 113 |
| 2023 8 | 71 | 22 | 93 |
| 2023 7 | 91 | 31 | 122 |
| 2023 6 | 91 | 26 | 117 |
| 2023 5 | 104 | 25 | 129 |
| 2023 4 | 73 | 19 | 92 |
| 2023 3 | 104 | 30 | 134 |
| 2023 2 | 76 | 17 | 93 |
| 2023 1 | 75 | 20 | 95 |
| 2022 12 | 79 | 30 | 109 |
| 2022 11 | 76 | 36 | 112 |
| 2022 10 | 67 | 42 | 109 |
| 2022 9 | 59 | 38 | 97 |
| 2022 8 | 59 | 60 | 119 |
| 2022 7 | 68 | 38 | 106 |
| 2022 6 | 103 | 41 | 144 |
| 2022 5 | 106 | 38 | 144 |
| 2022 4 | 81 | 46 | 127 |
| 2022 3 | 115 | 60 | 175 |
| 2022 2 | 77 | 46 | 123 |
| 2022 1 | 92 | 50 | 142 |
| 2021 12 | 84 | 43 | 127 |
| 2021 11 | 81 | 52 | 133 |
| 2021 10 | 73 | 62 | 135 |
| 2021 9 | 58 | 56 | 114 |
| 2021 8 | 60 | 54 | 114 |
| 2021 7 | 55 | 43 | 98 |
| 2021 6 | 57 | 50 | 107 |
| 2021 5 | 52 | 39 | 91 |
| 2021 4 | 74 | 43 | 117 |
| 2021 3 | 64 | 47 | 111 |
| 2021 2 | 45 | 18 | 63 |
| 2021 1 | 45 | 22 | 67 |
| 2020 12 | 50 | 16 | 66 |
| 2020 11 | 57 | 20 | 77 |
| 2020 10 | 83 | 13 | 96 |
| 2020 9 | 124 | 16 | 140 |
| 2020 8 | 80 | 9 | 89 |
| 2020 7 | 48 | 14 | 62 |
| 2020 6 | 50 | 17 | 67 |
| 2020 5 | 58 | 23 | 81 |
| 2020 4 | 27 | 19 | 46 |
| 2020 3 | 34 | 19 | 53 |
| 2020 2 | 37 | 24 | 61 |
| 2020 1 | 34 | 14 | 48 |
| 2019 12 | 41 | 36 | 77 |
| 2019 11 | 26 | 15 | 41 |
| 2019 10 | 40 | 18 | 58 |
| 2019 9 | 20 | 15 | 35 |
| 2019 8 | 58 | 21 | 79 |
| 2019 7 | 37 | 18 | 55 |
| 2019 6 | 39 | 21 | 60 |
| 2019 5 | 75 | 34 | 109 |
| 2019 4 | 69 | 69 | 138 |
| 2019 3 | 37 | 24 | 61 |
| 2019 2 | 46 | 24 | 70 |
| 2019 1 | 30 | 23 | 53 |
| 2018 12 | 36 | 29 | 65 |
| 2018 11 | 59 | 36 | 95 |
| 2018 10 | 67 | 23 | 90 |
| 2018 9 | 42 | 27 | 69 |
| 2018 8 | 2 | 0 | 2 |
| 2018 6 | 1 | 0 | 1 |
| 2018 5 | 1 | 0 | 1 |
| 2018 4 | 21 | 0 | 21 |
| 2018 3 | 14 | 0 | 14 |
| 2018 2 | 2 | 0 | 2 |
| 2018 1 | 11 | 0 | 11 |
| 2017 12 | 5 | 0 | 5 |
| 2017 11 | 10 | 0 | 10 |
| 2017 10 | 18 | 0 | 18 |
| 2017 9 | 5 | 0 | 5 |
| 2017 8 | 8 | 0 | 8 |
| 2017 7 | 15 | 4 | 19 |
| 2017 6 | 15 | 29 | 44 |
| 2017 5 | 17 | 31 | 48 |
| 2017 4 | 10 | 14 | 24 |
| 2017 3 | 5 | 45 | 50 |
| 2017 2 | 9 | 26 | 35 |
| 2017 1 | 6 | 11 | 17 |
| 2016 12 | 20 | 24 | 44 |
| 2016 11 | 28 | 23 | 51 |
| 2016 10 | 32 | 17 | 49 |
| 2016 9 | 46 | 32 | 78 |
| 2016 8 | 50 | 28 | 78 |
| 2016 7 | 39 | 30 | 69 |
| 2016 3 | 3 | 0 | 3 |
| 2015 12 | 2 | 0 | 2 |
| 2015 11 | 1 | 25 | 26 |
| 2015 10 | 2 | 36 | 38 |
| 2015 9 | 1 | 0 | 1 |
| 2015 7 | 1 | 0 | 1 |
| 2015 1 | 1 | 0 | 1 |
| 2014 12 | 3 | 1 | 4 |
| 2014 11 | 3 | 0 | 3 |
| 2014 10 | 2 | 0 | 2 |
| 2014 9 | 3 | 0 | 3 |
| 2014 8 | 3 | 0 | 3 |
| 2014 7 | 3 | 0 | 3 |
| 2014 6 | 12 | 2 | 14 |
Show all
